# Cdymax (India) Pharma Private Limited – FDA Inspection, Apr 25, 2025

Source: https://www.keypedia.com/records/fda_inspections/cdymax-india-pharma-private-limited/a643d37d-6f70-40f5-a91d-a549b5742e4b
Source feed: FDA_Inspections

> FDA inspection 1271325 of Cdymax (India) Pharma Private Limited, April 25, 2025. Classification: Official Action Indicated (OAI). Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1271325
- Company Name: Cdymax (India) Pharma Private Limited
- Inspection Date: 2025-04-25
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1118683 - 2020-01-31
- [FDA Inspection 1093684 - 2019-05-17](https://www.keypedia.com/records/fda_inspections/cdymax-india-pharma-private-limited/af0d07d5-0d83-4b81-886c-3d7911eee80b)
- FDA Inspection 940635 - 2015-08-14

## Related Officers

- [Arsen Karapetyan](https://www.keypedia.com/people/arsen-karapetyan/4000d909-277b-4533-992f-4e3627c8ce40)
- [Issuing Officer](https://www.keypedia.com/people/arsen-karpetvan/ebb53b85-3dad-40ef-b386-1a3a0bae57cb)
- [Issuing Officer](https://www.keypedia.com/people/arwaa-kampetya/92e30608-2e97-4929-8249-79a315e9715a)

Company: https://www.keypedia.com/companies/cdymax-india-pharma-private-limited/51bc8d84-9900-43c0-8e1c-9d2bd08b0ac4

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
